Trial Profile
An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jul 2009
Price :
$35
*
At a glance
- Drugs Fluorouracil (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- Sponsors Sanofi
- 14 Jul 2009 New trial record